Live Breaking News & Updates on Loop Diuretics

Stay updated with breaking news from Loop diuretics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the results from two proof-of-concept studies, RED DESERT and SAHARA, of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been published in the prestigious pe ....

United States , Cian Crosbie , Jeffrey Testani , Yale University , Company Or Sequanamedical , Company Premarket Approval , Serial Direct Sodium Removal , Heart Failure , Sequana Medical , Euronext Brussels , European Journal , Chief Executive Officer , Seattle Heart Failure , Premarket Approval , North American , Data Safety Monitoring Board , Loop Diuretics , Linical Studies , Red Desert , Euronext Brussels , The Company , Sequana Medical , Liver Disease ,